Paul Mainwaring COSA-IPOS Joint Scientific Meeting 2012

Abstracts this author is presenting:

• Phase 3 study COU-AA-301of abiraterone acetate (AA) plus prednisone (P) in metastatic castration-resistant prostate cancer (mCRPC): an exploratory analysis of prior docetaxel treatment and survival benefit — COSA Best of the Best Orals: Clinical Sciences